Polygenic Scores: How well can we separate genetics from the environment?
A person’s traits – such as their height or risk of disease – result from a complex interplay between the genes they inherit and the environments they experience over their lifetime. To cut through some of this complexity, human geneticists use a tool called a polygenic score, which attempts to predict a person’s traits solely from their genes (Rosenberg et al., 2019).
To build a polygenic score, geneticists first enroll a large number of people in a genome-wide association study (GWAS). For each participant, researchers measure numerous genetic variants across their genome, together with a trait of interest, and use this data to determine the extent to which different variants are associated with the trait. This information makes it possible to take the genome of someone who was not involved in the original GWAS and add up the effects of multiple genetic variants to calculate a polygenic score for that trait (Figure 1A). These scores have been used to predict a person’s risk of developing a disease (Torkamani et al., 2018), to study our evolutionary past (Rosenberg et al., 2019), and to help understand complex social outcomes (Harden and Koellinger, 2020).

Correcting biases in polygenic scores.
(A) A genome-wide associate study (GWAS) measures the trait of interest (phenotype) and the genotype of a sample of individuals and uses this data (middle graph) to see which genetic variants (represented by individual dots) are associated with the trait of interest (shown in red). This information is used to compute the polygenic score of individuals not in the original sample. Individuals with a higher polygenic score (orange) are predicted to have a higher trait value (e.g. to be taller or to have a greater risk of disease), while those with a lower polygenic score are predicted to have a lower trait value (bottom graph). (B) Mathieson and Zaidi simulated genetic data for a population that separated into subpopulations in the recent past; the environment was simulated as a six-by-six grid (left) in which environmental factors associated with the trait of interest vary smoothly from top to bottom. The uncorrected mean polygenic scores (top right) have a structure that clearly mirrors the structure in the environment. Correcting the scores with the 'common PCA' approach (middle right) does not solve this problem, but correction with the 'rare PCA' approach (bottom right) does. (C) However, when differences in the environmental factors were localized to a single square in the grid (shown in yellow), not even the rare PCA model could eliminate the correlation between genetic and environmental effects (indicated by asterix).
Image credit: Panel A – top (Stux, CC0), middle (Figure 1, Hu et al., 2016, CC BY 4.0), bottom (Jennifer Blanc); Panel B (Adapted from Figure 4, Zaidi and Mathieson, 2020).
However, efforts to use polygenic scores face substantial obstacles. All human populations exhibit genetic structure – variation in how genetically similar pairs of individuals are to one another – due to the complex history of geographic separation, population mixtures and migrations that have occurred throughout our evolutionary history. If this genetic structure correlates with patterns of environmental variation, it will cause many genetic variants to be incorrectly associated with a trait. This phenomenon, which is known as population stratification, will introduce biases into polygenic scores and undermine their purpose (which is to separate out the genetic component of trait variation).
To overcome this barrier, researchers would ideally measure the relevant environmental effects in the GWAS sample and include them as statistical controls in their analyses. However, it is difficult – if not impossible – to quantify all environmental effects on a given trait. Existing theory suggests that researchers can use the patterns of genetic variation they have already measured to model the genetic structure of the GWAS sample, and use this as statistical control instead (Song et al., 2015; Wang and Blei, 2019). In essence, because the problem arises from correlations between the environmental effects and patterns of genetic structure, it can be solved by controlling for either of them. The difficulty lies in how to correctly model this genetic structure. Geneticists favor a method called principal components analysis (PCA) (Price et al., 2006), as its simplicity and computational feasibility make it easy to apply to massive GWAS datasets. But the approach has limitations, and population stratification remains an issue in practice (Mathieson and McVean, 2012; Berg et al., 2019; Sohail et al., 2019).
Now, in eLife, Arslan Zaidi and Iain Mathieson from the University of Pennsylvania report which PCA models are the most effective at reducing bias in polygenic scores (Zaidi and Mathieson, 2020). To do this, they simulated the genetic data of a single population which had divided into spatially structured sub-groups within the recent past. They then simulated environmental effects on the trait and tested different PCA models to see how well each model controlled for them.
The results showed that the usual approach, known as ‘common PCA’, leads to polygenic scores that inappropriately mirror the environmental effects. Common PCA models calculate genetic structure by only measuring variants that appear in more than 5% of individuals in the GWAS sample. These common variants are typically ancient in origin, and therefore do not adequately capture the genetic structure of populations which have been spatially subdivided in the recent past. It is this failure to capture the genetic structure that results in biased polygenic scores.
On the other hand, rare variants, which appear in only a handful of individuals, are typically recent in origin and therefore reflect the history of recent subdivisions. Zaidi and Mathieson show that for this reason, PCA models built using patterns of genetic structure in rare variants (‘rare PCA’) eliminate biases from polygenic scores more effectively than the ‘common PCA’ technique (Figure 1B). However, this approach is not a panacea. When the environmental factors associated with the trait were localized to one geographic place (e.g. pollution localized to a particular city), even the rare PCA approach could not separate genetic effects from environmental biases (Figure 1C).
Zaidi and Mathieson also explore a more complicated set of simulations which are meant to more accurately mimic the patterns seen in real GWAS datasets, and find that the results are essentially identical to the simplified scenario described above. In all of their simulations, Zaidi and Mathieson know the ground truth, allowing them to experiment with different approaches designed to target the kind of bias they have simulated. In the real world, the ground truth is not known, so it is difficult to have complete confidence that stratification biases have been properly dealt with. Although a long-studied issue, these findings further demonstrate how separating genetic effects from environmental effects is still not a ‘solved’ problem in genetic studies (Lawson et al., 2020).
Studies that use polygenic scores have exploded in number over the past decade, riding a wave of well-founded optimism that they can open up new, otherwise inaccessible, avenues of research. But care is needed to ensure that this powerful tool is applied appropriately. Ultimately, the possibility for misleading results is an unavoidable risk, especially in research that is restricted to non-experimental settings. Zaidi and Mathieson provide several good recommendations for overcoming this, and suggest that a combination of the rare and common PCA approaches will minimize the amount by which environmental effects confound GWAS data. Moving forward, their results highlight the need for further statistical methods that more effectively deal with the biases introduced by environmental effects, especially for sharply distributed factors. In addition, more sensitive diagnostics are needed to assess how environmental effects impact polygenic scores.
References
-
Using genetics for social scienceNature Human Behaviour 4:567–576.https://doi.org/10.1038/s41562-020-0862-5
-
Interpreting polygenic scores, polygenic adaptation, and human phenotypic differencesEvolution, Medicine, and Public Health 2019:26–34.https://doi.org/10.1093/emph/eoy036
-
Testing for genetic associations in arbitrarily structured populationsNature Genetics 47:550–554.https://doi.org/10.1038/ng.3244
-
The personal and clinical utility of polygenic risk scoresNature Reviews Genetics 19:581–590.https://doi.org/10.1038/s41576-018-0018-x
-
The blessings of multiple causesJournal of the American Statistical Association 114:1574–1596.https://doi.org/10.1080/01621459.2019.1686987
Article and author information
Author details
Acknowledgements
We thank Arjun Biddanda, Xiaoheng Cheng, Graham Coop, Doc Edge and John Novembre for comments on earlier drafts, and Arslan Zaidi and Iain Mathieson for answering questions about their paper.
Publication history
Copyright
© 2020, Blanc and Berg
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 4,253
- views
-
- 302
- downloads
-
- 5
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Epidemiology and Global Health
- Microbiology and Infectious Disease
Background:
In many settings, a large fraction of the population has both been vaccinated against and infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Hence, quantifying the protection provided by post-infection vaccination has become critical for policy. We aimed to estimate the protective effect against SARS-CoV-2 reinfection of an additional vaccine dose after an initial Omicron variant infection.
Methods:
We report a retrospective, population-based cohort study performed in Shanghai, China, using electronic databases with information on SARS-CoV-2 infections and vaccination history. We compared reinfection incidence by post-infection vaccination status in individuals initially infected during the April–May 2022 Omicron variant surge in Shanghai and who had been vaccinated before that period. Cox models were fit to estimate adjusted hazard ratios (aHRs).
Results:
275,896 individuals were diagnosed with real-time polymerase chain reaction-confirmed SARS-CoV-2 infection in April–May 2022; 199,312/275,896 were included in analyses on the effect of a post-infection vaccine dose. Post-infection vaccination provided protection against reinfection (aHR 0.82; 95% confidence interval 0.79–0.85). For patients who had received one, two, or three vaccine doses before their first infection, hazard ratios for the post-infection vaccination effect were 0.84 (0.76–0.93), 0.87 (0.83–0.90), and 0.96 (0.74–1.23), respectively. Post-infection vaccination within 30 and 90 days before the second Omicron wave provided different degrees of protection (in aHR): 0.51 (0.44–0.58) and 0.67 (0.61–0.74), respectively. Moreover, for all vaccine types, but to different extents, a post-infection dose given to individuals who were fully vaccinated before first infection was protective.
Conclusions:
In previously vaccinated and infected individuals, an additional vaccine dose provided protection against Omicron variant reinfection. These observations will inform future policy decisions on COVID-19 vaccination in China and other countries.
Funding:
This study was funded the Key Discipline Program of Pudong New Area Health System (PWZxk2022-25), the Development and Application of Intelligent Epidemic Surveillance and AI Analysis System (21002411400), the Shanghai Public Health System Construction (GWVI-11.2-XD08), the Shanghai Health Commission Key Disciplines (GWVI-11.1-02), the Shanghai Health Commission Clinical Research Program (20214Y0020), the Shanghai Natural Science Foundation (22ZR1414600), and the Shanghai Young Health Talents Program (2022YQ076).
-
- Epidemiology and Global Health
Background:
The role of circulating metabolites on child development is understudied. We investigated associations between children’s serum metabolome and early childhood development (ECD).
Methods:
Untargeted metabolomics was performed on serum samples of 5004 children aged 6–59 months, a subset of participants from the Brazilian National Survey on Child Nutrition (ENANI-2019). ECD was assessed using the Survey of Well-being of Young Children’s milestones questionnaire. The graded response model was used to estimate developmental age. Developmental quotient (DQ) was calculated as the developmental age divided by chronological age. Partial least square regression selected metabolites with a variable importance projection ≥1. The interaction between significant metabolites and the child’s age was tested.
Results:
Twenty-eight top-ranked metabolites were included in linear regression models adjusted for the child’s nutritional status, diet quality, and infant age. Cresol sulfate (β=–0.07; adjusted-p <0.001), hippuric acid (β=–0.06; adjusted-p <0.001), phenylacetylglutamine (β=–0.06; adjusted-p <0.001), and trimethylamine-N-oxide (β=–0.05; adjusted-p=0.002) showed inverse associations with DQ. We observed opposite directions in the association of DQ for creatinine (for children aged –1 SD: β=–0.05; pP=0.01;+1 SD: β=0.05; p=0.02) and methylhistidine (–1 SD: β = - 0.04; p=0.04;+1 SD: β=0.04; p=0.03).
Conclusions:
Serum biomarkers, including dietary and microbial-derived metabolites involved in the gut-brain axis, may potentially be used to track children at risk for developmental delays.
Funding:
Supported by the Brazilian Ministry of Health and the Brazilian National Research Council.